ShareValue.ai

ShareValue scores for 1696.HK: Valuation 68, Quality 55, Growth 48, Health 65.

1696.HK
HKEX

Sisram Medical Ltd

HK$2.24(-0.88%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
68
Fair Value
Price vs Value
Quality
55
Moderate
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
65
Moderate
Financial Stability
Momentum
15
Bearish
Price Trend

Company Details

About

Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers a portfolio of products and treatments for clinical aesthetic indications, including hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. It also engages in pharmaceutical research and development activities. The company offers its products under the Alma, LMNT, Copulla, Profhilo, and Aliaxin brands. Sisram Medical Ltd was founded in 1999 and is headquartered in Caesarea, Israel.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026